WeGovy FlexTouch 0.5mg - CONSULTATION REQUIRED
This product is not available in the selected currency.
In Stock
Backordered
Out of Stock
Description
Important - Consultation Required
Supply of this medicine requires a completed medical questionnaire
and verification from prescribing pharmacist prior to your order being approved.
*Medical Questionnaire is sent via email once appointment is booked*
Wegovy® Flextouch 0.5mg Pen
Prescription Only Medicine (POM)
Wegovy® (semaglutide) FlexTouch 0.5mg Pen is a once-weekly prescription injection used as part of a medically supervised weight management programme for eligible adults.
Treatment is combined with a reduced-calorie diet, increased physical activity and ongoing lifestyle support to help achieve sustainable weight loss.
Before any prescription can be issued, you must:
• Book an online or in-person consultation with one of our GPhC-registered prescribing pharmacists.
• Complete a comprehensive medical questionnaire.
• Provide your height, weight and relevant medical history.
• Provide photographic identification and current body weight where requested.
• Supply any additional information requested by the pharmacist to verify your suitability.
Every order is individually assessed by an independent prescribing pharmacist.
A prescription will only be issued if treatment is considered safe, clinically appropriate and in your best interests. Completion of the consultation does not guarantee that a prescription will be issued.
About Wegovy
Active ingredient: Semaglutide
Strength: 0.5mg
Form: Multi-dose KwikPen pre-filled injection pen
Administration: Injected once weekly
Supply: One KwikPen containing four weekly doses (approximately 4 weeks of treatment)
Who may be suitable?
Wegovy may be suitable for adults who meet current prescribing criteria for weight management.
Suitability is determined following a full clinical assessment by the prescribing pharmacist, taking into account:
Body Mass Index (BMI)
Medical history
Current medications
Previous weight management treatments
Risk factors and contraindications
Who should not use Wegovy?
Wegovy is not suitable for everyone. It may not be appropriate if you:
Are pregnant or planning pregnancy
Are breastfeeding
Have certain pancreatic conditions
Have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Have other medical conditions where treatment may not be appropriate
Your pharmacist will discuss any potential risks during your consultation.
Possible side effects
Like all medicines, Wegovy can cause side effects.
The most common include:
Nausea
Vomiting
Diarrhoea
Constipation
Reduced appetite
Abdominal discomfort
Serious side effects are uncommon but can occur. Always read the Patient Information Leaflet supplied with your medication and seek medical advice if you experience severe or concerning symptoms.
Ongoing Support
Our prescribing pharmacists provide ongoing clinical monitoring throughout your treatment. Dose increases are only recommended where appropriate following assessment of your progress, side effects and treatment goals.
Please note: Product images are for illustrative purposes only and packaging may vary.
Wegovy® is a Prescription Only Medicine (POM). Supply is subject to a successful consultation and clinical assessment by a GPhC-registered prescribing pharmacist. You must book a consultation before treatment can be considered.
Supply of this medicine requires a completed medical questionnaire
and verification from prescribing pharmacist prior to your order being approved.
*Medical Questionnaire is sent via email once appointment is booked*
Wegovy® Flextouch 0.5mg Pen
Prescription Only Medicine (POM)
Wegovy® (semaglutide) FlexTouch 0.5mg Pen is a once-weekly prescription injection used as part of a medically supervised weight management programme for eligible adults.
Treatment is combined with a reduced-calorie diet, increased physical activity and ongoing lifestyle support to help achieve sustainable weight loss.
Before any prescription can be issued, you must:
• Book an online or in-person consultation with one of our GPhC-registered prescribing pharmacists.
• Complete a comprehensive medical questionnaire.
• Provide your height, weight and relevant medical history.
• Provide photographic identification and current body weight where requested.
• Supply any additional information requested by the pharmacist to verify your suitability.
Every order is individually assessed by an independent prescribing pharmacist.
A prescription will only be issued if treatment is considered safe, clinically appropriate and in your best interests. Completion of the consultation does not guarantee that a prescription will be issued.
About Wegovy
Active ingredient: Semaglutide
Strength: 0.5mg
Form: Multi-dose KwikPen pre-filled injection pen
Administration: Injected once weekly
Supply: One KwikPen containing four weekly doses (approximately 4 weeks of treatment)
Who may be suitable?
Wegovy may be suitable for adults who meet current prescribing criteria for weight management.
Suitability is determined following a full clinical assessment by the prescribing pharmacist, taking into account:
Body Mass Index (BMI)
Medical history
Current medications
Previous weight management treatments
Risk factors and contraindications
Who should not use Wegovy?
Wegovy is not suitable for everyone. It may not be appropriate if you:
Are pregnant or planning pregnancy
Are breastfeeding
Have certain pancreatic conditions
Have a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
Have other medical conditions where treatment may not be appropriate
Your pharmacist will discuss any potential risks during your consultation.
Possible side effects
Like all medicines, Wegovy can cause side effects.
The most common include:
Nausea
Vomiting
Diarrhoea
Constipation
Reduced appetite
Abdominal discomfort
Serious side effects are uncommon but can occur. Always read the Patient Information Leaflet supplied with your medication and seek medical advice if you experience severe or concerning symptoms.
Ongoing Support
Our prescribing pharmacists provide ongoing clinical monitoring throughout your treatment. Dose increases are only recommended where appropriate following assessment of your progress, side effects and treatment goals.
Please note: Product images are for illustrative purposes only and packaging may vary.
Wegovy® is a Prescription Only Medicine (POM). Supply is subject to a successful consultation and clinical assessment by a GPhC-registered prescribing pharmacist. You must book a consultation before treatment can be considered.
Opps
Sorry, it looks like some products are not available in selected quantity.